• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺表面活性物质膜的结构-功能关系:从生物物理学到治疗

Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy.

作者信息

Lopez-Rodriguez Elena, Pérez-Gil Jesús

机构信息

Departamento de Bioquimica y Biologia Molecular, Facultad de Biologia, Universidad Complutense de Madrid, Madrid, Spain; Institute for Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany; Biomedical Research in End Stage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, Hannover, Germany.

Departamento de Bioquimica y Biologia Molecular, Facultad de Biologia, Universidad Complutense de Madrid, Madrid, Spain.

出版信息

Biochim Biophys Acta. 2014 Jun;1838(6):1568-85. doi: 10.1016/j.bbamem.2014.01.028. Epub 2014 Feb 11.

DOI:10.1016/j.bbamem.2014.01.028
PMID:24525076
Abstract

Pulmonary surfactant is an essential lipid-protein complex to maintain an operative respiratory surface at the mammalian lungs. It reduces surface tension at the alveolar air-liquid interface to stabilise the lungs against physical forces operating along the compression-expansion breathing cycles. At the same time, surfactant integrates elements establishing a primary barrier against the entry of pathogens. Lack or deficiencies of the surfactant system are associated with respiratory pathologies, which treatment often includes supplementation with exogenous materials. The present review summarises current models on the molecular mechanisms of surfactant function, with particular emphasis in its biophysical properties to stabilise the lungs and the molecular alterations connecting impaired surfactant with diseased organs. It also provides a perspective on the current surfactant-based strategies to treat respiratory pathologies. This article is part of a Special Issue entitled: Membrane Structure and Function: Relevance in the Cell's Physiology, Pathology and Therapy.

摘要

肺表面活性物质是一种重要的脂质 - 蛋白质复合物,对于维持哺乳动物肺部的有效呼吸表面至关重要。它可降低肺泡气液界面的表面张力,以稳定肺部抵抗沿压缩 - 扩张呼吸周期作用的物理力。同时,表面活性物质整合了建立抵御病原体进入的主要屏障的要素。表面活性物质系统的缺乏或缺陷与呼吸道疾病相关,其治疗通常包括补充外源性物质。本综述总结了目前关于表面活性物质功能分子机制的模型,特别强调其稳定肺部的生物物理特性以及将受损表面活性物质与患病器官联系起来的分子改变。它还提供了当前基于表面活性物质治疗呼吸道疾病策略的观点。本文是名为:膜结构与功能:在细胞生理学、病理学和治疗中的相关性的特刊的一部分。

相似文献

1
Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy.肺表面活性物质膜的结构-功能关系:从生物物理学到治疗
Biochim Biophys Acta. 2014 Jun;1838(6):1568-85. doi: 10.1016/j.bbamem.2014.01.028. Epub 2014 Feb 11.
2
Understanding the principle biophysics concepts of pulmonary surfactant in health and disease.理解肺表面活性剂在健康和疾病中的基本生物物理概念。
Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F443-F451. doi: 10.1136/archdischild-2018-315413. Epub 2018 Dec 14.
3
Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions.肺表面活性物质膜和薄膜的结构:蛋白质及脂蛋白相互作用的作用
Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1676-95. doi: 10.1016/j.bbamem.2008.05.003. Epub 2008 May 11.
4
Protein-lipid interactions and surface activity in the pulmonary surfactant system.肺表面活性物质系统中的蛋白质-脂质相互作用及表面活性
Chem Phys Lipids. 2006 Jun;141(1-2):105-18. doi: 10.1016/j.chemphyslip.2006.02.017. Epub 2006 Mar 20.
5
Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films.组成、结构和机械性能决定了肺表面活性物质膜和片的性能。
Chem Phys Lipids. 2015 Jan;185:153-75. doi: 10.1016/j.chemphyslip.2014.09.002. Epub 2014 Sep 28.
6
Computer simulations of lung surfactant.肺表面活性剂的计算机模拟
Biochim Biophys Acta. 2016 Oct;1858(10):2431-2440. doi: 10.1016/j.bbamem.2016.02.030. Epub 2016 Feb 27.
7
Restoring pulmonary surfactant membranes and films at the respiratory surface.修复呼吸表面的肺表面活性物质膜和膜片。
Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1725-1739. doi: 10.1016/j.bbamem.2017.03.015. Epub 2017 Mar 21.
8
Lipid-protein interactions of hydrophobic proteins SP-B and SP-C in lung surfactant assembly and dynamics.肺表面活性物质组装与动力学中疏水蛋白SP - B和SP - C的脂-蛋白相互作用
Pediatr Pathol Mol Med. 2001 Nov-Dec;20(6):445-69. doi: 10.1080/pdp.20.6.445.469.
9
Palmitoylation as a key factor to modulate SP-C-lipid interactions in lung surfactant membrane multilayers.棕榈酰化作为调节肺表面活性物质膜多层结构中SP-C-脂质相互作用的关键因素。
Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):184-91. doi: 10.1016/j.bbamem.2014.10.009. Epub 2014 Oct 12.
10
Structural hallmarks of lung surfactant: Lipid-protein interactions, membrane structure and future challenges.肺表面活性剂的结构特征:脂质-蛋白相互作用、膜结构和未来的挑战。
Arch Biochem Biophys. 2021 May 30;703:108850. doi: 10.1016/j.abb.2021.108850. Epub 2021 Mar 20.

引用本文的文献

1
Genetic prediction of immune cells, inflammatory proteins, and metabolite-mediated association between gut microbiota and COPD: a Mendelian randomization study.免疫细胞、炎症蛋白以及肠道微生物群与慢性阻塞性肺疾病之间代谢物介导关联的遗传预测:一项孟德尔随机化研究
Sci Rep. 2025 Jul 1;15(1):21633. doi: 10.1038/s41598-025-05290-9.
2
The pristine unused pulmonary surfactant isolated from human amniotic fluid forms highly condensed interfacial films.从人羊水分离出的纯净未使用的肺表面活性物质形成高度浓缩的界面膜。
Physiol Rep. 2025 Jun;13(12):e70403. doi: 10.14814/phy2.70403.
3
Modeling Human Airway Epithelial Barrier Penetration Using Birch Bet v 1 and Alder Aln g 1 Pollen Allergens During Sensitization Process.
在致敏过程中使用桦树花粉过敏原Bet v 1和桤木花粉过敏原Aln g 1模拟人类气道上皮屏障穿透
Int J Mol Sci. 2025 May 28;26(11):5169. doi: 10.3390/ijms26115169.
4
Surfactant protein SP-B: one ring to rule the molecular and biophysical mechanisms of the pulmonary surfactant system.表面活性蛋白SP-B:掌控肺表面活性物质系统分子与生物物理机制的关键一环。
Biophys Rev. 2025 Mar 18;17(2):653-666. doi: 10.1007/s12551-025-01285-y. eCollection 2025 Apr.
5
Bacterial expression, purification and folding of exceptionally hydrophobic and essential protein: Surfactant Protein-B (SP-B).异常疏水且必需的蛋白质——表面活性蛋白B(SP-B)的细菌表达、纯化及折叠
PLoS One. 2025 Apr 25;20(4):e0321446. doi: 10.1371/journal.pone.0321446. eCollection 2025.
6
Systematic Analysis of Composition, Interfacial Performance and Effects of Pulmonary Surfactant Preparations on Cellular Uptake and Cytotoxicity of Aerosolized Nanomaterials.肺表面活性剂制剂对雾化纳米材料的组成、界面性能、细胞摄取及细胞毒性影响的系统分析
Small Sci. 2021 Oct 23;1(12):2100067. doi: 10.1002/smsc.202100067. eCollection 2021 Dec.
7
Dissecting Large-Scale Structural Transitions in Membrane Transporters Using Advanced Simulation Technologies.利用先进模拟技术剖析膜转运蛋白中的大规模结构转变
J Phys Chem B. 2025 Apr 17;129(15):3703-3719. doi: 10.1021/acs.jpcb.5c00104. Epub 2025 Mar 18.
8
The Immune Modulatory Role of Surfactants in Infection.表面活性剂在感染中的免疫调节作用
J Inflamm Res. 2025 Feb 26;18:2909-2922. doi: 10.2147/JIR.S507526. eCollection 2025.
9
and studies of the interaction between glucocorticoid drug mometasone furoate and model lung surfactant monolayer.以及糠酸莫米松糖皮质激素药物与模型肺表面活性剂单层之间相互作用的研究。
RSC Adv. 2025 Feb 26;15(8):5951-5964. doi: 10.1039/d5ra00004a. eCollection 2025 Feb 19.
10
Effects of Nicotine on the Thermodynamics and Phase Coexistence of Pulmonary Surfactant Model Membranes.尼古丁对肺表面活性物质模型膜的热力学和相共存的影响。
Membranes (Basel). 2024 Dec 11;14(12):267. doi: 10.3390/membranes14120267.